Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
- GO: Molecular function
- GO: Cellular component
- GO: Biological process
Phenotypes
Genetic Variation
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: cbln17 ENSDARG00000088911

.

Description

cerebellin 17 [Source:ZFIN;Acc:ZDB-GENE-111109-4]

Location

Chromosome 10: 21,867,307-21,870,457 forward strand.

GRCz11:CM002894.2

About this gene

This gene has 3 transcripts (splice variants), 226 orthologues and 19 paralogues.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	Flags
ENSDART00000126629.3	cbln17-201	972	244aa	ENSDARP00000107429.2	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical, APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1, 5' truncation in transcript evidence prevents annotation of the start of the CDS.CDS 5' incomplete,
ENSDART00000158807.2	cbln17-202	765	No protein	-	An alternatively spliced transcript believed to contain intronic sequence relative to other, coding, transcripts of the same gene.Retained intron	-
ENSDART00000170169.2	cbln17-203	602	No protein	-	An alternatively spliced transcript believed to contain intronic sequence relative to other, coding, transcripts of the same gene.Retained intron	-

.

Summary

.

.